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Abstract. A DNA polymerase activity associated with the detergent insoluble cytoskeletal
fraction has been identified in dividing and non-dividing rat hepatocytes and a hepatoma (the 
Zajdela Ascitic Hepatoma). About 35 % of the enzyme is found associated with the cytoskeletal 
fraction of non-dividing cells as compared to about 3–6 % of the enzyme in dividing cells even 
though the dividing cells contain larger amounts of the extranuclear enzyme. The properties of 
the enzyme are similar to those of DNA polymerase-α. It is suggested that the association of the 
enzyme with the cytoskeletal fraction has functional significance.
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Introduction 
 
The intracellular location of DNA polymerase-α, the major DNA replicating enzyme
has been controversial (Sarngadharan et alb., 1978). Recent immunocytochemical 
studies have indicated a predominantly nuclear location of the enzyme (Bensch et al., 
1982; Matsukage et al., 1983; Nakamura et al., 1984). But biochemical extraction 
procedures (Bollum and Potter, 1958; Keir, 1965) as well as certain immunofluores-
cence studies have indicated a large cytoplasmic pool (Brown et al., 1981). There are, in
addition, other reports indicating the association of the enzyme with cytoplasmic 
membrane (Baril et al., 1970, 1971; Davis et al., 1971). We have also reported a DNA 
polymerase-α like activity in the plasma membranes of a rat hepatoma, closely 
associated with the detergent insoluble fraction (Shashikant et al., 1983). 
A major discrepancy in presenting an exclusively nuclear location of the enzyme
(Bensch et al., 1982; Matsukage et al., 1983; Nakamura et al., 1984) arises from the fact 
that the site of synthesis of the enzyme is expected to be the cytoplasm. It is therefore 
surprising not to find the enzyme in the cytoplasm by immunocytochemical methods. 
We have now adopted a modified approach to address this question. Treatment of cells 
with a nonionic detergent solubilizes most of the cellular proteins (soluble fraction) 
leaving behind an insoluble material consisting of filamentous structure along with the 
nuclei. Intact nuclei can then be separated by double detergent treatment and low speed 
centrifugation. This supernatant is the cytoskeletal fraction (CSF) (Cervera et al., 1981).
 
 
 
Abbreviations used: ZAH, Zajdela Ascitic Hepatoma; CSF, cytoskeletal fraction; PM, plasma membrane; 
PBS, phosphate buffered saline; NP 40, nonidet Ρ 40; NEM, N-ethylmaleimide; PMSF, phenylmethylsul-
phonylfiuoride; SDS, sodium dodecyl sulphate.
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We have examined the distribution of DNA polymerase-α in these fractions from 
resting and dividing rat liver cells and a rat hepatoma (Zajdela Ascitic Hepatoma, ZAH) 
cells. 
 
Materials and methods  
 
Chemicals 
 
Radioactively labelled nucleoside triphosphates were obtained from Amersham,
England, cold triphosphates and synthetic templates from PL Biochemicals. All other 
chemicals were from Sigma Chemical Company, St. Louis, Missouri, USA. 
 
Cell suspension 
 
Livers were obtained from both normal and partially hepatectomised adult Wistar rats
(30–36 h after hepatectomy). Fetal livers were obtained from 18–19 days old embryos.
After perfusion with cold phosphate buffered saline (PBS) (135 mM NaCl,
2·75mMKCl,1·5mMKH2PO4, 8 mM Na2HPO4, pH7·2), the tissues were minced
and gently homogenized in PBS (10 ml/gm of tissue) in a loose fitting homogenizer.
After passing the homogenate through anylon mesh (size 50–70 µ) it was centrifuged at 
700g to pellet the cells. The pellets were resuspended in 10 mM PIPES buffer, pH 6·8, 
containing 10 mM KCl, 1 mM phenyl methyl sulphonyl fluoride (PMSF) and 10% 
sucrose (w/v). 
 
Tumour cells 
 
ZAH cells were obtained from the ascitic fluid from tumour bearing Wistar rats 
maintained by serial transplantation in the laboratory (Shashikant et al., 1983). The 
cells were harvested from the peritoneal cavity of the animals between the 5th and 7th 
day of transplantation, diluted immediately with PBS and pelleted down at 700 g and 
were washed twice with PBS.
 
Sub cellular fractionation 
 
Fractionations were performed according to the procedures already described (Cervera
et al., 1981). All operations were carried out at 4°C. Cells were resuspended at 2–4 
× 106/ml in PIPES buffer and NP40 was added slowly to make the detergent 
concentration 1 % (v/v). The suspension was stirred for 15 min and then centrifuged at 
1,000 g for 10 min. The supernatant (soluble fraction) was collected and preserved; the 
pellet was washed and resuspended in 1/3 ofthe original volume of buffer (10 mM Tris, 
pH 7·4, 10 mM NaCl, 1·5 mM MgCl2, 5 mM CaCl2 and 1 mM PMSF) and gently
homogenised in a loose fitting homogenizer in the presence of 1 % Tween 40 and 0·5 % 
deoxycholate. The nuclei were pelleted by centrifugation at 750 g for 10 min. The 
nuclear pellets were routinely examined under the microscope to ensure that they were 
intact. The supernatant containing the CSF was centrifuged at 90,000 g for 90 min and 
the pellet obtained was taken up in 1 ml of Tris buffer. Plasma membranes (PM) were 
prepared using the method of Lesko et al. (1973) and PM skeleton was prepared as
described earlier (Shashikant et al., 1983). 
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Assays of DNA polymerase (Shashikant et al., 1983) 5'-nucleotidase (Gurd and
Evans, 1974) alkaline phosphatase (Pekarthy et al., 1972) succinic dehydrogenase (Earl 
and Korner, 1965) and pyrophosphatase (Shatton et al., 1981) were carried out 
according to the methods described earlier.
Protein concentrations were determined by the Lowry method (Lowry et al.,1951) in
the presence of sodium dodecyl sulphate (SDS). Gel electrophoresis (Laemmli, 1970) 
and subsequent staining (Oakely et al., 1980) were carried out as described elsewhere. 
 
Results 
 
Cytoskeletal fractions 
 
Detergent treatment solubilizes about 70 % of protein which includes marker enzymes 
such as pyrophosphatase, alkaline phosphatase and succinic dehydrogenase. However, 
5'-nucleotidase, an enzyme found in association with plasma membrane skeleton of 
liver cells (data not shown), was retained on the CSF indicating a certain commonality 
between PM skeleton and CSF. Electrophoretic analysis further revealed (figure 1) 
many common proteins between PM skeleton (lane 2) and CSF (lane 1) of liver except 
for proteins Ρ 80, Ρ 59, Ρ 41 and Ρ 40 which are specific to CSF. A similar comparison of 
ZAH-CSF (lane 3) with ZAH-PM skeleton (lane 4) shows protein Ρ 120, P8 3, P77, P68 
and Ρ51 are specific to ZAH-CSF. However, PM skeleton of ZAH appears to have a
distinct profile as compared to CSFs and PM skeleton of liver. A comparison of protein 
profiles of CSF fractions of liver and ZAH show distinct patterns with characteristic 
proteins in each cell type.
 
DNA polymerase activity in the soluble fraction and in CSF. 
 
The DNA polymerase activities determined using activated calf thymus DNA as 
template from both soluble and CSF were inhibited by NEM. The percentage inhibition 
in the presence of 1 mM N-ethylmaleimide (NEM) varied between 82–87 % in the 
different samples tested. None of the samples examined showed any activity with 
synthetic polymers such as poly rA:oligo dT or poly rC:oligo dG or with a ribopoly-
meric template, AMV RNA as templates (results not shown). These properties suggest
that the enzyme is likely to be DNA polymerase-α and also rule out contamination of
DNA polymerising activities such as γ-polymerase and reverse transcriptase in the
activity that we are assaying.
 
Distribution of DNA polymerase activity 
 
The amounts of DNA polymerase activity from the different samples examined are 
shown in table 1. The total amount of enzyme present in the soluble and CSFs taken 
together is much higher in the dividing cells. Further, there is a dramatic difference 
between dividing and non-dividing cells in the distribution pattern of the enzyme in the 
soluble fraction and CSF. In the adult liver cells 35 % of the enzyme is found in CSF 
whilst the amount of enzyme present in this fraction of dividing cells is only 3–6 %. Even
when the total amount of extranuclear enzyme present in adult liver cells is lower
compared to that in dividing cells the absolute quantity of enzyme (per/g) found
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Figure 1. SDS Polyacrylamide gel electrophoresis (10%) profile of proteins from plasma
membrane skeletons and CSF isolated from liver and ZAH cells. Lane 1, liver CSF; Lane 2,
liver PM skeleton; Lane 3, ZAH CSF; Lane 4, ZAH PM skeleton; Lane 5, molecular weight
markers (obtained from Pharmacia). Protein bands: Lane 1, bands 1,2,3 and 4 are Ρ 80, Ρ 59,
P41 and P40 respectively. Lane 3: bands 1, 2, 3, 4 and 5 are Ρ120, P83, P77, P68 and P51
respectively. 
 
fractions obtained from diving cells. Table 1 also shows that there is considerable
variation in the amount of enzyme present per mg of protein in the different samples. In
CSFs this quantity is largest for adult liver cells.
associated with CSF in these cells is larger than that present in the corresponding
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Table 1.  Extranuclear DNA polymerase activity in the soluble and cytoskeletal fractions of dividing and
non-dividing cells. 
 
a Activity expressed as p mol of [3H]-TMP incorporated in 15 min. reaction using activated calf thymus
DNA as template. Values reported are averages of 3 separate determinations in each case.  
b Calucated from net weight of starting tissue.  
C Adult liver and regenerating liver have 3 × 107 cells/g tissue whilst liver has 1 × 108 cells /gm tissue and 
ZAH has 2 × 108 cells/g tissue.  
d sol, .soluble fraction. 
 
 
 
 
 
Discussion 
 
We have demonstrated biochemically the presence and characteristic distribution of
DNA polymerase-α in the soluble and CSFs of resting and dividing cells. These
observations are in sharp contrast with most immunocytochemical studies indicating
an exclusive nuclear location for DNA polymerase-α. As the enzyme must be
synthesized in the cytoplasm, it is surprising that no enzyme can be detected at the site 
of synthesis by immunocytochemical methods. It is therefore likely that these methods
especially those making use of monoclonal antibodies may be detecting specific
epitopes, which may be masked in the enzyme present outside the nucleus.
Differences in the state of association of DNA polymerase-α with nuclear matrix in
resting and dividing cells have been documented (Smith and Berenzney, 1982). In the 
present experiments we demonstrate a differential association of the enzyme with CSF
in resting and dividing cells. Such an association and possibly a functional role of the 
association is not surprising in light of the increasing realization of the role of CSF in a
variety of cellular events. It is likely that the cytoskeletal framework may play a role in
the transport of DNA polymerase-α within the cell. When the cells are dividing, any 
transport of the enzyme through the mediation of the skeletal framework could be
more active and the steady state concentration of the amount of enzyme remaining 
associated with CSF could be lower. In the resting phase, part of the enzyme 
synthesized at the time of division could remain associated with skeletal elements
probably better protected, to be readily available at the onset of cell division.
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